Introduction
Materials and methods
Study participants
Clinical and laboratory measurements
Statistical analysis
Results
The correlation between SUA and urinary prostaglandins
SUA | P value | |
---|---|---|
PGD | -0.356 | 0.160 |
PGE1 | -0.615 | 0.009** |
PGE2 | -0.824 | < 0.001*** |
PGI2 | 0.278 | 0.280 |
TXA2 | -0.450 | 0.070 |
TXB2 | 0.273 | 0.345 |
6-keto-PGF1a | 0.434 | 0.121 |
The correlation between urinary prostaglandins and urinary uric acid excretion
FEua | P value | Cua | P value | |
---|---|---|---|---|
PGD | 0.317 | 0.215 | 0.216 | 0.405 |
PGE1 | 0.541 | 0.025* | 0.273 | 0.288 |
PGE2 | 0.556 | 0.020* | 0.518 | 0.033* |
PGI2 | -0.209 | 0.420 | -0.221 | 0.415 |
TXA2 | 0.233 | 0.367 | 0.370 | 0.143 |
TXB2 | -0.137 | 0.641 | -0.289 | 0.317 |
6-keto-PGF1a | -0.408 | 0.147 | -0.431 | 0.124 |
B | SE | Beta | t | P value | |
---|---|---|---|---|---|
Cua | 38.045 | 16.205 | 0.542 | 2.348 | 0.033* |
Age | -4.032 | 1.663 | -0.442 | -2.424 | 0.028 |
BMI | -5.342 | 7.690 | -0.224 | -0.695 | 0.498 |
eGFR | 1.093 | 2.019 | 0.108 | 0.541 | 0.596 |
TG | -35.074 | 34.665 | -0.416 | -1.012 | 0.328 |
TC | 31.959 | 110.457 | 0.224 | 0.289 | 0.776 |
HDL | -211.519 | 156.206 | -0.385 | -1.354 | 0.196 |
LDL | 7.741 | 121.349 | 0.045 | 0.064 | 0.950 |
Differences of PGE2 in urinary uric acid excretion markers
Variables | All (n = 38) | FEua1 (n = 24) FEua < 4.212% | FEua2 (n = 14) FEua ≥ 4.212% | P value |
---|---|---|---|---|
Age(years) | 46.08 ± 13.97 | 46.96 \(\pm\) 12.70 | 44.57 ± 16.32 | 0.618 |
BMI (kg/m2) | 24.68 ± 4.67 | 24.36 \(\pm 2.32\) | 25.25 ± 7.21 | 0.578 |
eGFR (ml/min/1.73 m2) | 89.25 ± 13.46 | 92.36 \(\pm 13.88\) | 85.35 ± 12.37 | 0.183 |
SUA | 479.71 ± 100.40 | 513.54 ± 91.39 | 421.71 ± 90.42 | 0.005** |
BG | 5.14 ± 0.70 | 5.20 ± 0.57 | 5.04 ± 0.87 | 0.549 |
TG | 2.35 ± 1.69 | 2.49 ± 1.52 | 2.10 ± 2.00 | 0.583 |
TC | 4.86 ± 0.97 | 4.92 ± 1.00 | 4.77 ± 0.97 | 0.688 |
24-hUV(mL) | 2203.95 ± 951.39 | 2448.13 \(\pm 969.31\) | 1785.36 ± 784.27 | 0.036* |
24-hUua (mmol) | 3.28 ± 1.11 | 3.26 \(\pm 1.10\) | 3.32 ± 1.16 | 0.871 |
PGD (pg/ml) | 272.52 ± 175.24 | 264.72 \(\pm 179.99\) | 287.47 ± 172.50 | 0.672 |
PGE1 (pg/ml) | 287.56 ± 59.47 | 283.73 \(\pm 52.29\) | 294.90 ± 73.31 | 0.605 |
PGE2 (pg/ml) | 635.61 ± 124.21 | 619.83 ± 108.31 | 665.87 ± 150.68 | 0.305 |
PGI2(pg/ml) | 104.86 ± 34.94 | 103.54 ± 36.10 | 107.39 ± 34.02 | 0.762 |
TXA2(pg/ml) | 80.87 ± 34.98 | 83.31 ± 32.45 | 80.47 ± 31.41 | 0.805 |
TXB2 (pg/ml) | 254.62 ± 60.08 | 268.25 \(\pm 64.22\) | 232.61 ± 46.92 | 0.093 |
6-keto-PGF1α (pg/ml) | 614.73 ± 228.51 | 643.02 ± 232.79 | 569.02 ± 222.73 | 0.367 |
Variables | All (n = 38) | Cua1 (n = 20) FEua < 4.859 ml/min/1.73m2 | Cua2 (n = 18) FEua ≥ 4.859 ml/min/1.73m2 | P value |
---|---|---|---|---|
Age(years) | 46.08 ± 13.97 | 46.00 \(\pm 14.56\) | 46.17 ± 13.70 | 0.971 |
BMI (kg/m2) | 24.68 ± 4.67 | 23.69 \(\pm 2.67\) | 25.78 ± 6.09 | 0.172 |
eGFR (ml/min/1.73 m2) | 89.25 ± 13.46 | 91.00 \(\pm 15.71\) | 87.35 ± 10.83 | 0.492 |
SUA | 479.71 ± 100.40 | 520.10 ± 97.15 | 434.83 ± 85.66 | 0.007** |
BG | 5.14 ± 0.70 | 5.14 ± 0.60 | 5.12 ± 0.84 | 0.936 |
TG | 2.35 ± 1.69 | 2.39 ± 1.60 | 2.28 ± 1.88 | 0.853 |
TC | 4.86 ± 0.97 | 4.90 ± 0.97 | 4.81 ± 1.01 | 0.799 |
24-hUV(mL) | 2203.95 ± 951.39 | 2071.50 \(\pm 874.17\) | 2351.11 ± 1035.55 | 0.373 |
24-hUua (mmol) | 3.28 ± 1.11 | 2.70 \(\pm 0.82\) | 3.92 ± 1.06 | P < 0.001*** |
PGD (pg/ml) | 272.52 ± 175.24 | 249.76 \(\pm 171.46\) | 301.46 ± 179.72 | 0.393 |
PGE1 (pg/ml) | 287.56 ± 59.47 | 281.11 \(\pm 59.73\) | 296.16 ± 60.07 | 0.467 |
PGE2 (pg/ml) | 635.61 ± 124.21 | 590.65 ± 116.51 | 695.56 ± 110.94 | 0.011* |
PGI2 (pg/ml) | 104.86 ± 34.94 | 107.32 ± 39.90 | 101.58 ± 28.00 | 0.638 |
TXA2(pg/ml) | 80.87 ± 34.98 | 82.52 ± 33.19 | 82.09 ± 30.65 | 0.969 |
TXB2 (pg/ml) | 254.62 ± 60.08 | 269.76 \(\pm 65.81\) | 237.59 ± 49.47 | 0.121 |
6-keto-PGF1α (pg/ml) | 614.73 ± 228.51 | 616.55 ± 260.62 | 612.68 ± 194.65 | 0.962 |